NEW JOURNEY HEALTH TECHNOLOGY GROUP CO.,LTD Financials New Journey Health Technology Group Co.,LTD
Equities
002219
CNE1000009R5
Healthcare Facilities & Services
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.47 CNY | +0.41% |
|
+8.81% | -18.48% |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 6,416 | 4,458 | 3,301 | 6,827 | 12,861 | 10,335 |
| Enterprise Value (EV) 1 | 9,512 | 6,336 | 4,909 | 6,692 | 13,588 | 11,761 |
| P/E ratio | -4.53 x | -1.8 x | -63.2 x | -18.4 x | 82.6 x | 333 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 1.67 x | 1.21 x | 1.18 x | 2.26 x | 4.08 x | 2.88 x |
| EV / Revenue | 2.48 x | 1.72 x | 1.75 x | 2.22 x | 4.31 x | 3.28 x |
| EV / EBITDA | -37.8 x | 25.6 x | 14.3 x | 56.2 x | 36.3 x | 32.9 x |
| EV / FCF | 22.1 x | 3.14 x | 64.6 x | 26.4 x | -18.9 x | -14.7 x |
| FCF Yield | 4.53% | 31.9% | 1.55% | 3.79% | -5.28% | -6.81% |
| Price to Book | 2.37 x | 22.9 x | 24.7 x | 4.4 x | 7.46 x | 4.71 x |
| Nbr of stocks (in thousands) | 1,865,236 | 1,865,236 | 1,865,236 | 1,865,236 | 3,264,164 | 3,410,759 |
| Reference price 2 | 3.440 | 2.390 | 1.770 | 3.660 | 3.940 | 3.030 |
| Announcement Date | 4/29/19 | 4/29/20 | 4/28/21 | 4/28/22 | 4/13/23 | 4/17/24 |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 3,838 | 3,684 | 2,806 | 3,016 | 3,153 | 3,590 |
| EBITDA 1 | -251.5 | 247.2 | 344.4 | 119.1 | 374.8 | 357.2 |
| EBIT 1 | -478.7 | 117.1 | 179.3 | -35.57 | 229.8 | 168.5 |
| Operating Margin | -12.47% | 3.18% | 6.39% | -1.18% | 7.29% | 4.69% |
| Earnings before Tax (EBT) 1 | -1,334 | -2,437 | 9.991 | -362.4 | 187.5 | 10.26 |
| Net income 1 | -1,418 | -2,520 | -52.24 | -371.4 | 155.6 | 30.78 |
| Net margin | -36.94% | -68.38% | -1.86% | -12.32% | 4.94% | 0.86% |
| EPS 2 | -0.7601 | -1.327 | -0.0280 | -0.1991 | 0.0477 | 0.009100 |
| Free Cash Flow 1 | 430.8 | 2,018 | 76.03 | 253.4 | -717.3 | -800.8 |
| FCF margin | 11.22% | 54.78% | 2.71% | 8.4% | -22.75% | -22.3% |
| FCF Conversion (EBITDA) | - | 816.57% | 22.08% | 212.78% | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 4/29/19 | 4/29/20 | 4/28/21 | 4/28/22 | 4/13/23 | 4/17/24 |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 3,096 | 1,878 | 1,608 | - | 728 | 1,427 |
| Net Cash position 1 | - | - | - | 135 | - | - |
| Leverage (Debt/EBITDA) | -12.31 x | 7.598 x | 4.669 x | - | 1.941 x | 3.994 x |
| Free Cash Flow 1 | 431 | 2,018 | 76 | 253 | -717 | -801 |
| ROE (net income / shareholders' equity) | -38.5% | -163% | -23.3% | -42.1% | 9.8% | 1.95% |
| ROA (Net income/ Total Assets) | -3.15% | 1.07% | 2.3% | -0.39% | 2.33% | 1.79% |
| Assets 1 | 45,046 | -235,339 | -2,269 | 96,151 | 6,683 | 1,715 |
| Book Value Per Share 2 | 1.450 | 0.1000 | 0.0700 | 0.8300 | 0.5300 | 0.6400 |
| Cash Flow per Share 2 | 0.1900 | 0.0700 | 0.0900 | 1.090 | 0.1700 | 0.1700 |
| Capex 1 | 220 | 216 | 217 | 199 | 222 | 195 |
| Capex / Sales | 5.74% | 5.86% | 7.72% | 6.59% | 7.03% | 5.44% |
| Announcement Date | 4/29/19 | 4/29/20 | 4/28/21 | 4/28/22 | 4/13/23 | 4/17/24 |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -18.48% | 1.16B | |
| -14.25% | 85.35B | |
| +14.46% | 81.95B | |
| +9.37% | 28.99B | |
| -11.40% | 16.98B | |
| -0.36% | 16.85B | |
| +0.22% | 15.35B | |
| +4.32% | 12.42B | |
| -2.34% | 11.88B | |
| +32.69% | 12.19B |
- Stock Market
- Equities
- 002219 Stock
- Financials New Journey Health Technology Group Co.,LTD
